Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 22

Showing 22 citing articles:

The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine
Kalpesh Mahajan, Sankha Bhattacharya
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 8, pp. 686-721
Closed Access | Times Cited: 10
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles
Jiayi Liu, Junyong Wu, Taili Chen, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 7
Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy
Bao-Toan Nguyen Dang, Ramesh Duwa, Sooyeun Lee, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 587-608
Closed Access | Times Cited: 4
Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy: Addressing Chemotherapy-Induced Disabilities
Mohamed Taha Yassin, Fatimah Al-Otibi, Sarah A. Al-Sahli, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4234-4234
Open Access | Times Cited: 4
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access
An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy
Zhen Zhang, Xu Chen, Ningqiang Gong, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 993-1005
Closed Access
Advancing Eco-friendly Biomedicine: Sustainable Nanocomposites as Platforms for Genetic Vaccines
Amin Hamidi, Mahla Poudineh
(2025), pp. 303-356
Closed Access
Advances in Drug Delivery Integrated with Regenerative Medicine: Innovations, Challenges, and Future Frontiers
Manoochehr Rasekh, Muhammad Sohail Arshad, Zeeshan Ahmad
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 456-456
Open Access
Advanced Nanobiomaterial-Mediated Radio-Immunotherapy in Malignant Cancer
Ning Han, Jun Hu, Liu‐Gen Li, et al.
(2025), pp. 35-50
Closed Access
Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation
Siyuan Luo, Yueyan Yang, Liuting Chen, et al.
Acta Biomaterialia (2024) Vol. 181, pp. 402-414
Closed Access | Times Cited: 4
Current Trends and Innovative Approaches in Cancer Immunotherapy
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Resiquimod-loaded cationic liposomes cure mice with peritoneal carcinomatosis and induce specific anti-tumor immunity
Po-Han Chao, Vanessa Chan, Jiamin Wu, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 362-371
Open Access | Times Cited: 2
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Ying‐Hong Shi, Donglin Hao, Hui Qian, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Nanotherapeutics for Macrophage Network Modulation in Tumor Microenvironments: Targets and Tools
Renwei Li, Jing Huang, Yuhao Wei, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13615-13651
Open Access | Times Cited: 2
Bi-specific nanoparticle-based engager capable of in situ activation of anti-tumor immune responses for postoperative cancer immunotherapy
Jialei Hao, Yu Zhao, Chunxiong Zheng, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 150068-150068
Closed Access | Times Cited: 1
Nanotechnology and Immunetherapy: reduction of hepatotoxicity and anti-antineoplastic efficiency
Irami Araújo-Filho, Amália Cínthia Meneses do Rêgo
JOURNAL OF SURGICAL AND CLINICAL RESEARCH (2024) Vol. 15, Iss. 1, pp. 59-78
Open Access | Times Cited: 1
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Approaches and challenges in cancer immunotherapy pathways
Μαρία Καπρίτσου
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 3, pp. 378-380
Open Access
Tumor-associated macrophages and cancer metastasis
Morkoss Fakhry, Dina M. Abo‐Elmatty, Asmaa Ramadan, et al.
Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences (2024) Vol. 8, Iss. 1, pp. 63-69
Open Access
Immunotherapy of Diseases and Nanotechnology: Current State and Prospects
O. F. Piminov, R. V. Sahaidak-Nikitіuk, Anna I. Kvitchata, et al.
Journal of organic and pharmaceutical chemistry (2024) Vol. 22, Iss. 1, pp. 13-21
Open Access
Albumin nanocapsules and nanocrystals for efficient intracellular drug release
Sharafudheen Pottanam Chali, Jaana Westmeier, Franziska K. Krebs, et al.
Nanoscale Horizons (2024) Vol. 9, Iss. 11, pp. 1978-1989
Open Access
Unveiling Nanoparticle-Immune Interactions: How Super-Resolution Imaging Illuminates the Invisible
Herath D. W. Herath, Ying S. Hu
Nanoscale (2024)
Closed Access
Page 1

Scroll to top